Drug(薬物リスト) DrugBank | All Description Patterns

e.g. "Sirolimus", "アダリムマブ"

ABCDEFGH I JKLMNOPQRSTUVWXYZother

34 / 17,542 descriptions

No. 薬物名(臨床試験情報から抽出) DrugBank KEGG DRUG
💬 Info on mouse-over
KEGG GENES
💬 Info on mouse-over
KEGG PATHWAY 指定難病告示番号
💬 Info on mouse-over
1 As - - - - 6件: 46, 53, 96, 97, 215, 271 💬
2 Calcium Calcium - - - 27件: 6, 13, 19, 46, 49, 51, 53, 56, 68, 75, 79, 84, 93, 94, 95, 96, 97, 186, 214, 215, 222, 224, 235, 265, 274, 298, 299 💬
3 Calcium gluconate Calcium 1件: D00935 💬 - - 3件: 214, 215, 235 💬
4 Coenzyme q10 Ubidecarenone 1件: D01065 💬 - - 12件: 2, 5, 6, 8, 10, 18, 46, 57, 113, 193, 214, 215 💬
5 Cpx - - - - 2件: 215, 299 💬
6 Device: cellvizio 100 series system with confocal miniprobes - - - - 1件: 215 💬
7 Dexmedetomidine Dexmedetomidine 2件: D00514, D01205 💬 3件: ADRA2A, ADRA2B, ADRA2C 💬 2件: Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 12件: 2, 4, 6, 21, 34, 46, 70, 113, 212, 215, 226, 280 💬
8 Dobutamin Dobutamine 4件: D00632, D03879, D03880, D03881 💬 1件: ADRB1 💬 10件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 215 💬
9 Dobutamine Dobutamine 4件: D00632, D03879, D03880, D03881 💬 1件: ADRB1 💬 10件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 3件: 57, 58, 215 💬
10 Eplerenone Eplerenone 1件: D01115 💬 1件: NR3C2 💬 1件: Aldosterone-regulated sodium reabsorption 4件: 75, 113, 210, 215 💬
11 Fentanyl Fentanyl 2件: D00320, D01399 💬 1件: OPRM1 💬 3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 4件: 46, 70, 215, 231 💬
12 Fentanyl (high dose) Fentanyl 2件: D00320, D01399 💬 1件: OPRM1 💬 3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 1件: 215 💬
13 Fentanyl (low dose) Fentanyl 2件: D00320, D01399 💬 1件: OPRM1 💬 3件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction 1件: 215 💬
14 Fentanyl (low dose) + dexmedetomidine Dexmedetomidine 4件: D00320, D00514, D01205, D01399 💬 4件: ADRA2A, ADRA2B, ADRA2C, OPRM1 💬 4件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, cGMP-PKG signaling pathway 1件: 215 💬
15 Fluorescite - - - - 1件: 215 💬
16 Gradient - - - - 4件: 58, 86, 149, 215 💬
17 Ketamine Ketamine 2件: D00711, D08098 💬 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 5件: 13, 70, 113, 156, 215 💬
18 Losartan Losartan 2件: D00357, D08146 💬 1件: AGTR1 💬 16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 18件: 17, 19, 36, 46, 58, 66, 67, 85, 96, 97, 98, 113, 164, 167, 179, 215, 222, 299 💬
19 Losartan potassium Losartan 3件: D00357, D08146, D08403 💬 1件: AGTR1 💬 16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 5件: 36, 98, 167, 179, 215 💬
20 Other: dobutamine Dobutamine 4件: D00632, D03879, D03880, D03881 💬 1件: ADRB1 💬 10件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 215 💬
21 Other: transthoracic echocardiography at rest, during plr, hg and cpx (including blood gas analysis in both groups). additionally fallot patients will undergo routine blood testings. - - - - 1件: 215 💬
22 Potassium Potassium 1件: D08403 💬 - - 10件: 36, 46, 66, 67, 98, 115, 167, 179, 215, 235 💬
23 Procedure: b-lines se - - - - 3件: 58, 86, 215 💬
24 Procedure: coronary flow reserve se - - - - 3件: 58, 86, 215 💬
25 Procedure: diastolic function se - - - - 3件: 58, 86, 215 💬
26 Procedure: left ventricular contractile reserve se - - - - 3件: 58, 86, 215 💬
27 Procedure: left ventricular outflow tract gradient se - - - - 3件: 58, 86, 215 💬
28 Procedure: mitral regurgitation se - - - - 3件: 58, 86, 215 💬
29 Procedure: pulmonary hemodynamics se - - - - 3件: 58, 86, 215 💬
30 Procedure: tof repair with trans-annular patch vs preservation of pv - - - - 1件: 215 💬
31 Pv - - - - 3件: 13, 97, 215 💬
32 Recombinant human brain natriuretic peptide (rhbnp) - - - - 1件: 215 💬
33 Sodium citrate Sodium citrate 2件: D01781, D05855 💬 - - 4件: 67, 214, 215, 235 💬
34 Tranexamic acid Tranexamic acid 1件: D01136 💬 1件: PLG 💬 4件: Complement and coagulation cascades, Influenza A, Neuroactive ligand-receptor interaction, Staphylococcus aureus infection 5件: 46, 70, 215, 227, 288 💬

先頭へ